Pulmonary Complications following Cytoreductive Surgery and Perioperative Chemotherapy in 147 Consecutive Patients

Table 3

Pulmonary adverse events grade I through grade IV. There was a total of 26 pulmonary adverse events in 14 patients.

Organ System	Absolute number/%	Grade I	Grade II-symptomatic and medical treatment	Grade III-invasive intervention	Grade IV-ICU care or return to operating room
Pleural effusion	10/4.6%	Asymptomatic 0%	Diuretics required 3/1.4%	Thoracentesis required 4/1.8%	Compromised, chest tube insertion 3/1.4%
Respiratory distress	9/4.2%	Mild symptom 0%	Oxygen therapy or medications required 2/0.9%	Endotracheal intubation 5/2.3%	Tracheostomy required 2/0.9%
Pneumonia	7/3.2%	Minimal symptoms 3/1.4%	Antibiotics and respiratory therapy 4/1.8%	Bronchoscopy 0%	Intubation required 0%